Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Multivalent Recombinant OspA Vaccine Candidate Against Lyme Borreliosis, In Healthy Adults Age
Brief Summary:
Observer-blind, partially randomized, multi-center dose escalation Phase I study in healthy adults below 40 years of age.
180 subjects will be enrolled in 6 treatment groups (different doses; different formulation: with/without adjuvant); vaccinations will be given I.M.(intramuscular) into the deltoid region on Days 0, 28 and 56. Study participants will be followed up until one year after first vaccination.